CARFILZOMIB vs CASIRIVIMAB\IMDEVIMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CARFILZOMIB vs CASIRIVIMAB\IMDEVIMAB: Safety Overview
| Metric | CARFILZOMIB | CASIRIVIMAB\IMDEVIMAB |
|---|---|---|
| Total FAERS Reports | 21,814 | 4,248 |
| Deaths Reported | 3,448 | 137 |
| Death Rate | 15.8% | 3.2% |
| Hospitalizations | 7,502 | 1,351 |
| Average Patient Age | 64.7 yrs | 54.3 yrs |
| % Female Patients | 42.6% | 55.4% |
| FDA Approval Date | Jul 20, 2012 | N/A |
| Manufacturer | Onyx Pharmaceuticals, Inc. | N/A |
| Route | INTRAVENOUS | N/A |
| Marketing Status | Prescription | N/A |